Please provide your email address to receive an email when new articles are posted on . “Bile acid diarrhea is a common yet underrecognized cause of chronic watery diarrhea. In most countries, ...

Colesevelam is a generic prescription medication. The Food and Drug Administration (FDA) has approved it to help lower low-density lipoprotein (LDL) cholesterol in certain adults and children ages 10 ...

Silver Spring, MD - The US Food and Drug Administration has approved an expanded indication for colesevelam HCl tablets and a new powder for oral suspension (Welchol, Daiichi Sankyo) as an adjunct to ...

Please provide your email address to receive an email when new articles are posted on . The addition of colesevelam to a niacin regimen appears to further decrease LDL cholesterol while counteracting ...

May 9, 2011 (San Diego, California) — Colesevelam (Welchol, Daiichi-Sankyo Pharmaceuticals) might not be a first choice for many clinicians in the treatment of type 2 diabetes; however, a post hoc ...

No randomised controlled trials (RCTs) were identified that compared colesevelam with placebo or other treatments in people with bile acid malabsorption. One published RCT was identified that compared ...

Discover comprehensive details about Colesevelam Hcl, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

For hypercholesterolemia- The recommended dose is one 3.75-gram packet once daily or one 1.875-gram packet twice daily. For Type 2 Diabetes- The recommended dose is 6 tablets once daily or 3 tablets ...

Colesevelam has been suggested as a promising alternative treatment for patients with type 2 diabetes mellitus (T2DM) who are intolerant to statins or who have an elevated LDL cholesterol level ...

ROCHESTER, MINN. -- Colesevelam hydrochloride appears to be an effective lipid-lowering agent that significantly reduces low-density lipoprotein (LDL) cholesterol levels, according to a study ...

No randomised controlled trials (RCTs) were identified that compared colesevelam with placebo or other treatments in people with bile acid malabsorption. One published RCT was identified that compared ...